GSK submits shingles vaccine application in Japan for over 18s
(Sharecast News) - Pharma giant GlaxoSmithKline on Tuesday said it had submitted a regulatory application Japan's Ministry of Health, Labour and Welfare (MHLW) for its Shingrix shingles vaccine for adults aged 18 years and older who are at increased risk.
Read more